Reach the investors backing rounds like this
Backed by TTT Medtech Fund, FIRST Fund +2 more · verified emails and LinkedIn on Datapile

Amsterdam’s Phosphoenix raises €1.3 million to advance neuroprosthesis for profound blindness - EU-Startups
Phosphoenix is an Amsterdam-based MedTech startup developing a neuroprosthetic system for people with profound blindness. Their system uses a proprietary Fountain Probe with over 1,000 microelectrodes to directly stimulate the brain's visual pathway, bypassing damage to the eyes. This €1.3 million financing round will support preparations for their first-in-human clinical study and further development of their neurostimulation system.
Amsterdam’s Phosphoenix raises €1.3 million to advance neuroprosthesis for profound blindness EU-Startups

| Sep 17, 2026 | Proba | $1.0M | — | Netherlands |
| Sep 15, 2026 | Boxd | $2.0M | Pre-seed | Netherlands |
| Sep 14, 2026 | Fortaegis | $50.0M | — | Netherlands |
| Sep 10, 2026 | Phoenix Metals | $4.0M | — | Netherlands |
You just read who funded Phosphoenix. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 15 investor contact unlocks a month, no card required.